Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

Abbott has announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the ...

In a report released on December 20, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...

Abbott Laboratories' board has raised the quarterly dividend by 7.3%, to 59 cents, making it 53 straight years that the healthcare-products company has boosted its payout. The new quarterly rate, ...

In a report released today, Adam Maeder from Piper Sandler maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens new tab said on Monday they have reached an agreement to settle all patent disputes between them related to ...

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and ...

Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

Yoor: As a global leader in healthcare, it is often critical to have a local footprint to deliver the right products at the right value. Being present in a market enables Abbott to better ...

Illinois-based Abbott Laboratories (ABT) is a global healthcare company. It is focused on discovering, developing, and manufacturing a wide range of healthcare products. The company's operations ...